Hospital of The Rockefeller Institute for Medical Research, New York.
J Exp Med. 1912 Nov 1;16(5):665-79. doi: 10.1084/jem.16.5.665.
These experiments demonstrate that protective substances are usually present in the blood of patients recovering from lobar pneumonia. As a rule, the appearance of protective bodies in the blood, when demonstrable, coincides rather sharply with the period of critical fall in temperature and the disappearance of symptoms. These substances are not present in the blood in any measurable degree before the crisis, but afterward they may reach a considerable concentration. In certain instances, protective substances either become evident some time after the occurrence of the crisis, or cannot be demonstrated at any period of the disease. Experiments in which it is possible to test serum against an homologous strain of pneumococcus yield in the majority of cases evidence of the presence of protective bodies; whereas in those in which stock cultures are used, the serum, as a rule, shows no protection. The development of specific protective substances in the serum of patients with lobar pneumonia suggests that these bodies may play a part in the mechanism of recovery.
这些实验证明,在从大叶性肺炎中康复的患者的血液中通常存在保护物质。通常,当可检测到保护性抗体出现在血液中时,它与体温急剧下降和症状消失的时期相当吻合。这些物质在危机之前不会以任何可测量的程度存在于血液中,但之后它们可能达到相当高的浓度。在某些情况下,保护物质要么在危机发生后一段时间才变得明显,要么在疾病的任何阶段都无法证明。在可以用同源肺炎球菌株测试血清的实验中,大多数情况下都有证据表明存在保护性抗体;而在使用库存培养物的实验中,血清通常没有保护作用。大叶性肺炎患者血清中特异性保护性物质的发展表明,这些物质可能在恢复机制中起作用。